EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Thromboelastometric assessment of the haemostatic effect of tranexamic acid as an adjunct to prophylactic platelet transfusions in patients with haematological malignancies undergoing intensive chemotherapy: A pilot study

Guillaume Simoens, Elisabeth Daguenet, Audrey Tientcheu, Thomas Fatrara, Bernard Tardy, Jérôme Cornillon, Emmanuelle Tavernier, Thomas Lecompte, Corinne Frere, Emilie Chalayer iD

Vox Sanguinis · 2025

DOI: 10.1111/vox.70165 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Vox Sanguinis, 2025. Verfasst von Guillaume Simoens und 9 weiteren Autor:innen. Beteiligte Einrichtung: SAINBIOSE, UMR 1059, INSERM, Jean Monnet University, Saint-Etienne, France. Hauptthemen laut MEDLINE: Tranexamic Acid, Platelet Transfusion, Hematologic Neoplasms, Thrombelastography. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Institut de Cancérologie du Centre Hospitalier de Saint-Etienne.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Tranexamic acid (TXA) as an adjunct to prophylactic platelet transfusion is sometimes used to prevent bleeding in patients with malignancies experiencing chemotherapy‐induced thrombocytopenia. However, there is little biological evidence in support. This pilot exploratory study aimed to evaluate the haemostatic efficacy of TXA before and after platelet transfusion versus platelet transfusion alone in patients with haematological malignancies experiencing chemotherapy‐induced thrombocytopenia. Materials and Methods Rotational thromboelastometry (ROTEM; EXTEM, tissue plasminogen activator [tPA]‐EXTEM and FIBTEM) was used to assess the haemostatic effect of these treatments.

Results

Eighteen patients were randomized to receive platelet transfusion and either 3 or 1.5 g of TXA per day or to be observed. At enrolment, ROTEM parameters were similar across groups. TXA alone did not affect EXTEM clot formation time (CFT) or maximum clot firmness (MCF). A trend towards increased EXTEM CFT and MCF values 2 h after platelet transfusion was observed. The effect of TXA was witnessed by the increase in tPA‐EXTEM lysis index at 60 min (LI60). In the observation group, tPA‐EXTEM LI60 also significantly increased after platelet transfusion. The World Health Organization (WHO) rates for grade ≥2 bleeding and the median number of platelet transfusions were similar across all groups.

Conclusion

Platelet transfusion as well as TXA decreased fibrinolysis for this patient population. This could be explained by the plasminogen activator inhibitor 1 contained in platelets. Future research should explore other alternative treatments and the utility of viscoelastometric testing to guide platelet transfusions, particularly in cases of bleeding or platelet transfusion refractoriness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidPlatelet TransfusionHematologic NeoplasmsThrombelastographyThrombocytopeniaAntifibrinolytic AgentsHumansPilot ProjectsMaleFemaleMiddle AgedAdultAgedHemorrhage

Stichwörter der Autor:innen

bleedingchemotherapy‐induced thrombocytopeniahaematological malignanciesplatelet transfusionthromboelastometrytranexamic acid

Substanzen

Tranexamic AcidAntifibrinolytic Agents

Autor:innen und Institutionen

  • SAINBIOSE, UMR 1059, INSERM, Jean Monnet University, Saint-Etienne, France.
  • Division of Clinical Hematology, University Hospital of Saint-Etienne, Saint-Etienne, France.
  • Clinical Investigation Center CIC-EC 1408, University Hospital of Saint-Etienne, Saint-Etienne, France.
  • Faculty of Medicine, University of Lorraine, Nancy, France.
  • Vascular Medicine Division, University Hospital, Nancy, France.
  • Division of Laboratory Hematology, Pitié Salpêtrière-Charles-Foix, AP-HP, Paris, France.

ORCID-Profile: Emilie Chalayer

Förderung

  • Institut de Cancérologie du Centre Hospitalier de Saint-Etienne

Zitieren

APA

Simoens, G., Daguenet, E., Tientcheu, A., Fatrara, T., Tardy, B., Cornillon, J., Tavernier, E., Lecompte, T., Frere, C., & Chalayer, E. (2025). Thromboelastometric assessment of the haemostatic effect of tranexamic acid as an adjunct to prophylactic platelet transfusions in patients with haematological malignancies undergoing intensive chemotherapy: A pilot study. Vox Sanguinis. https://doi.org/10.1111/vox.70165

Vancouver

Simoens G, Daguenet E, Tientcheu A, Fatrara T, Tardy B, Cornillon J, et al. Thromboelastometric assessment of the haemostatic effect of tranexamic acid as an adjunct to prophylactic platelet transfusions in patients with haematological malignancies undergoing intensive chemotherapy: A pilot study. Vox Sanguinis. 2025. doi:10.1111/vox.70165

BibTeX
@article{Simoens2025,
  author = {Simoens, Guillaume and Daguenet, Elisabeth and Tientcheu, Audrey and Fatrara, Thomas and Tardy, Bernard and Cornillon, Jérôme and Tavernier, Emmanuelle and Lecompte, Thomas and Frere, Corinne and Chalayer, Emilie},
  title = {Thromboelastometric assessment of the haemostatic effect of tranexamic acid as an adjunct to prophylactic platelet transfusions in patients with haematological malignancies undergoing intensive chemotherapy: A pilot study},
  journal = {Vox Sanguinis},
  year = {2025},
  doi = {10.1111/vox.70165}
}
Kostenlos starten →